Women in Science
What progress has the industry made in advancing women in leadership, R&D, and clinical roles?
Pharma's Almanac
PAO-07-25-NI-13Jul 30, 2025
Biomanufacturing
What are the most significant manufacturing hurdles in biopharma and how can they be addressed?
Pharma's Almanac
PAO-06-25-RT-02Jun 30, 2025
Digital Health
How is the shift toward digital health solutions transforming the pharmaceutical industry, and what challenges remain?
Pharma's Almanac
PAO-06-25-RT-01Jun 30, 2025
Gene Editing
What are the key ethical and regulatory considerations as gene editing technologies advance toward widespread clinical use?
Pharma's Almanac
PAO-05-25-RT-02Jun 17, 2025
Health Equity
How is the pharmaceutical industry addressing global health inequities?
Pharma's Almanac
PAO-05-25-RT-01Jun 17, 2025
Next-Gen Biologics
What do you see as the next big modality in biologics, and what factors are driving innovation in this space?
Pharma's Almanac
PAO-04-25-RT-01May 01, 2025
Drug Approvals
How can the industry balance the need for faster drug approvals with the necessity of ensuring patient safety and efficacy?
Pharma's Almanac
PAO-03-25-RT-01Mar 26, 2025
RNA
What new opportunities are emerging for mRNA technology, and how is the portfolio of applications expanding beyond vaccines?
Pharma's Almanac
PAO-03-25-RT-02Mar 26, 2025
AI
Is AI truly transforming drug development, or are we still navigating through the hype?
Pharma's Almanac
PAO-02-25-RT-01Feb 26, 2025
Supply Chain
What strategies are ensuring supply chain resilience in a post-COVID world?
Pharma's Almanac
PAO-02-25-RT-02Feb 26, 2025
Sustainability
How can pharma manufacturing align with green initiatives while maintaining efficiency and compliance?
Pharma's Almanac
PAO-01-25-RT-02Jan 31, 2025
Personalized
How do you see advances in personalized medicine reshaping patient care, and what are the key challenges and opportunities ahead?
Pharma's Almanac
PAO-01-25-RT-01Jan 31, 2025
Innovation
How is the pharmaceutical industry integrating innovations from adjacent industries to enhance drug development and production?
Pharma's Almanac
PAO-11-24-RT-02Oct 28, 2024
BIOSECURE Act
Can you discuss the anticipated impacts of the BIOSECURE Act on the biopharmaceutical landscape?
Pharma's Almanac
PAO-11-24-RT-01Oct 28, 2024
Changing Roles
How are Advancements in Technology Reshaping the Roles and Capabilities of CDMOs and CROs in the Drug Development Life Cycle?
Pharma's Almanac
PAO-08-24-RT-01Aug 07, 2024
Global Access
How Can (Bio)pharmaceutical Companies Contribute to Improving Global Access to Essential Medications?
Pharma's Almanac
PAO-08-24-RT-02Aug 07, 2024
Digitalization
How can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?
Pharma's Almanac
PAO-06-24-RT-02Jun 24, 2024
Investment
What are the Current Investment Trends in the Pharmaceutical Industry, and How are They Influencing the Sector’s Direction?
Pharma's Almanac
PAO-06-24-RT-01Jun 24, 2024
Commitment to ESG Principles
How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?
Pharma's Almanac
PAO-03-24-CL-03Mar 08, 2024
Accelerating Product Development
What strategies are being employed to accelerate product development and commercialization without compromising quality?
Pharma's Almanac
PAO-03-24-CL-02Mar 08, 2024